Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Application of a Phenotype-Based Predictive Analytic in a Phase Ib Study of Selinexor and Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Somedeb Ball, Michael T. Byrne, Melissa A Fischer, Farrukh T. Awan, Ben K. Tomlinson, Tess Stopczynski, Lokesh Patil, Christine J. Gu, Chris Leonardi, Katherine J. Walsh, Gregory Dan Ayers, Ashwin Kishtagari, Kateryna Fedorov, Markus D. Lacher, Joseph Wagner, Sanjay R Mohan, Michael R. Savona

Blood (2024) 144 (Supplement 1): 6012.

https://doi.org/10.1182/blood-2024-209403

Published: 2024

Journal Articles

Prediction of Volasertib Sensitivity in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax Plus Azacitidine

Lokesh Patil, Christine J. Gu, Cristina Tognon, Nicola Long, Kara Johnson, Melissa A Fischer, Somedeb Ball, Michael R. Savona, Chris Leonardi, Joseph Wagner, Glenn Michelson, Markus D. Lacher

Blood (2024) 144 (Supplement 1): 5818.

https://doi.org/10.1182/blood-2024-206299

Published: 2024

Journal Articles

A Phase 2 Study with Volasertib for Ven-HMA Relapsed/Refractory Acute Myeloid Leukemia Patients Guided By a Predictive Precision Medicine Platform

Joseph Wagner, Markus D. Lacher, Christine J. Gu, Christopher Leonardi, Gabriel Mannis

Blood (2023) 142 (Supplement 1): 5952.

https://doi.org/10.1182/blood-2023-186953

Published: 2023

Journal Articles

Prediction of Clinical Response to Venetoclax Plus Decitabine in AML Using a 7-Day Ex Vivo Assay

Markus D Lacher, Michelle A Richardson, Steven A Schaffert, Ryosuke Kita, Marianne T Santaguida, Erica K Anderson, Jordan Roselli, Wade Anderson, Arisa Paul, Christine Gu, Kathryn Vanderlaag, Zhihong Zeng, Abhishek Maiti, Courtney D. DiNardo, Marina Konopleva

Blood (2021) 138 (Supplement 1): 3464.

https://doi.org/10.1182/blood-2021-148891

Published: 2021